Firstly, the protein levels of the active phosphorylated forms of several proteins — the expression of which was incremented in prostate cancer, concretely CREB, ERK1/2 and JNK —, were measured in BeWo cells (Fig. 4A) treated or not with α2M*. The gene discussed is MAPK3; the disease is prostate carcinoma.